AKLI - Akili Inc Stock Price, Fair Value and News

$7.700.00 (0.00%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

AKLI Price Action

Last 30 days

2.4%

Last 90 days

48.3%

AKLI RSI Chart

AKLI Valuation

Market Cap

605.9M

Price/Earnings (Trailing)

-12.48

Price/Sales (Trailing)

20.16

EV/EBITDA

-11.8

Price/Free Cashflow

-12.42

AKLI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AKLI Fundamentals

AKLI Revenue

Revenue (TTM)

1.7M

Rev. Growth (Yr)

266.86%

Rev. Growth (Qtr)

54.12%

AKLI Earnings

Earnings (TTM)

-48.5M

Earnings Growth (Yr)

52.86%

Earnings Growth (Qtr)

12.42%

AKLI Profitability

Operating Margin

49.05%

EBT Margin

-2889.87%

Return on Equity

-96.69%

Return on Assets

-72.06%

Free Cashflow Yield

-8.05%

AKLI Investor Care

Shares Dilution (1Y)

0.78%

Diluted EPS (TTM)

-0.61

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	774.7K	1.2M	0	1.7M
2022	484.3K	430.5K	376.8K	323.0K
2021	0	2.8M	1.7M	538.0K
2020	0	0	0	3.9M

Get all data in R, Python etc through our Historical Stock Data APIs

About Akili Inc

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. Akili, Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.

CEO	Dr. Walter Edward Martucci II, Ph.D.
WEBSITE	akiliinteractive.com
SECTOR	Healthcare
INDUSTRY	Health Information Services
EMPLOYEES	111

Akili Inc Frequently Asked Questions

What is the ticker symbol for Akili Inc? What does AKLI stand for in stocks?

AKLI is the stock ticker symbol of Akili Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Akili Inc (AKLI)?

As of Tue Jul 02 2024, market cap of Akili Inc is 605.87 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AKLI stock?

You can check AKLI's fair value in chart for subscribers.

Is Akili Inc a good stock to buy?

The fair value guage provides a quick view whether AKLI is over valued or under valued. Whether Akili Inc is cheap or expensive depends on the assumptions which impact Akili Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AKLI.

What is Akili Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Jul 02 2024, AKLI's PE ratio (Price to Earnings) is -12.48 and Price to Sales (PS) ratio is 20.16. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AKLI PE ratio will change depending on the future growth rate expectations of investors.